ArticlePlastic and reconstructive surgery. Global open2026
Clinic-based Treatment of Type B Ulnar Polydactyly Saves Costs Compared With Treatment in the Operating Room.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: One in 500 children in the United States is born with polydactyly. Type B ulnar polydactyly excision is often performed in the operating room (OR) but can also be conducted in an office setting. This study compares costs for patients/families and healthcare systems between these settings. Methods: A retrospective review from January 2019 to December 2023 included patients who underwent type B ulnar polydactyly excision. Patients were categorized into in-office or OR groups. Patient demographics and financial data were analyzed using independent-samples Results: Of 114 patients, 64 underwent in-office excision and 50 underwent OR excision. Total charges to the payer were significantly lower for in-office excision compared with OR ($2130 versus $10,731; Conclusions: In-office excision of type B ulnar polydactyly significantly reduces costs for patients, families, and healthcare systems. Shifting care to the office can alleviate OR demand and decrease financial burdens. These cost differences should inform care planning and resource allocation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.